TrialThe oncologist2025

Pegylated liposomal doxorubicin + cyclophosphamide followed by taxane as adjuvant therapy for early-stage breast cancer: a randomized controlled trial.

Lichen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.